JP2005502679A5 - - Google Patents

Download PDF

Info

Publication number
JP2005502679A5
JP2005502679A5 JP2003524594A JP2003524594A JP2005502679A5 JP 2005502679 A5 JP2005502679 A5 JP 2005502679A5 JP 2003524594 A JP2003524594 A JP 2003524594A JP 2003524594 A JP2003524594 A JP 2003524594A JP 2005502679 A5 JP2005502679 A5 JP 2005502679A5
Authority
JP
Japan
Prior art keywords
hyperalgesia
days
mechanical
measured
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/009662 external-priority patent/WO2003020287A2/en
Publication of JP2005502679A publication Critical patent/JP2005502679A/ja
Publication of JP2005502679A5 publication Critical patent/JP2005502679A5/ja
Pending legal-status Critical Current

Links

JP2003524594A 2001-08-30 2002-08-29 慢性疼痛の処置方法およびそのための組成物 Pending JP2005502679A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31589801P 2001-08-30 2001-08-30
PCT/EP2002/009662 WO2003020287A2 (en) 2001-08-30 2002-08-29 Methods for the treatment of chronic pain anc compositions therefor

Publications (2)

Publication Number Publication Date
JP2005502679A JP2005502679A (ja) 2005-01-27
JP2005502679A5 true JP2005502679A5 (enExample) 2006-01-05

Family

ID=23226545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524594A Pending JP2005502679A (ja) 2001-08-30 2002-08-29 慢性疼痛の処置方法およびそのための組成物

Country Status (4)

Country Link
US (2) US20030144234A1 (enExample)
EP (1) EP1423128A2 (enExample)
JP (1) JP2005502679A (enExample)
WO (1) WO2003020287A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383748A2 (en) * 2000-12-22 2004-01-28 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US20040147503A1 (en) * 2002-06-04 2004-07-29 Sheila Zipfeil Novel compounds and compositions as cathepsin inhibitors
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
AR043692A1 (es) * 2003-02-06 2005-08-10 Novartis Ag 2-cianopirrolopirimidinas y sus usos farmaceuticos
US7384970B2 (en) 2003-03-24 2008-06-10 Irm Llc Inhibitors of cathepsin S
US7109243B2 (en) 2003-03-24 2006-09-19 Irm Llc Inhibitors of cathepsin S
AU2004233582B2 (en) * 2003-04-28 2008-05-15 Novartis Ag Pharmaceutical compositon comprising a cathepsin S inhibitor and an opioid
EP1797883A3 (en) * 2003-04-28 2007-08-01 Novartis AG Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid
US7173051B2 (en) 2003-06-13 2007-02-06 Irm, Llc Inhibitors of cathepsin S
WO2005014849A2 (en) * 2003-07-03 2005-02-17 Euro-Celtique, S.A. Genes associated with responses to neuropathic pain
US7256207B2 (en) 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
US7297714B2 (en) * 2003-10-21 2007-11-20 Irm Llc Inhibitors of cathepsin S
GB0324542D0 (en) * 2003-10-21 2003-11-26 Novartis Ag Organic compounds
TW200614993A (en) 2004-06-11 2006-05-16 Akzo Nobel Nv 4-phenyl-pyrimidine-2-carbonitrile derivatives
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US7939642B2 (en) * 2005-04-09 2011-05-10 Fusion Antibodies Limited Antibody and uses thereof
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
WO2006125105A2 (en) * 2005-05-19 2006-11-23 Wyeth Methods and compositions for treating and diagnosing multiple sclerosis
US20090099264A1 (en) 2005-06-02 2009-04-16 Merck Frosst Canada Ltd. Fluoroalkylamine Derivatives as Cathepsin Inhibtors
US7326715B2 (en) 2005-09-23 2008-02-05 N.V. Organon 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
US7687515B2 (en) 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
WO2007097720A2 (en) * 2006-02-21 2007-08-30 Agency For Science, Technology And Research Method and reagents for treating hepatic fibrosis and inflammation
EP2010570B8 (en) * 2006-04-10 2015-01-21 Fusion Antibodies Limited Therapy against cathepsin s
US20080200454A1 (en) * 2007-02-15 2008-08-21 Ameriks Michael K Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20090118274A1 (en) * 2007-02-15 2009-05-07 Darin Allen Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080269241A1 (en) * 2007-02-15 2008-10-30 Darin Allen Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080207683A1 (en) * 2007-02-15 2008-08-28 Darin Allen Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20090099157A1 (en) * 2007-02-15 2009-04-16 Ameriks Michael K Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
US7932251B2 (en) 2007-07-16 2011-04-26 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
CN102264710B (zh) 2008-12-19 2014-11-05 美迪维尔英国有限公司 半胱氨酸蛋白酶抑制剂
US8026236B2 (en) 2009-01-16 2011-09-27 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
EP2293072A1 (en) * 2009-08-31 2011-03-09 Sanofi-Aventis Use of cathepsin H
EP2582660B1 (en) 2010-06-16 2015-07-22 Medivir UK Ltd New cathepsin s protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
US5795977A (en) * 1989-09-15 1998-08-18 Metabasis Therapeutics, Inc. Water soluble adenosine kinase inhibitors
US5714484A (en) * 1993-12-08 1998-02-03 Prototek, Inc. α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
JP2000509376A (ja) * 1996-04-22 2000-07-25 マサチューセッツ インスティテュート オブ テクノロジー カテプシンｓの阻害を通しての免疫応答の抑制
CA2360740A1 (en) * 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
GB0121033D0 (en) * 2001-08-30 2001-10-24 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005502679A5 (enExample)
Gonzalez et al. Gingival bleeding on probing: relationship to change in periodontal pocket depth and effect of sodium hypochlorite oral rinse
Do Amaral et al. A clinical follow‐up study of the periodontal conditions of RPD abutment and non‐abutment teeth
Mizumori et al. Masticatory laterality–evaluation and influence of food texture
MXPA03010382A (es) Composiciones modeladoras del cabello, con retencion durable, y metodo de empleo.
CY1107649T1 (el) Συνδυασμος ο οποιος περιεχει ενα αντιφολικο αλας και παραγοντα ελαττωσης μεθυλομηλονικου οξεος
ATE282988T1 (de) Nichtinvasive bestimmung von herzzeitvolumen, pulmonaren blutfluss und blutgasgehalt
JP2007228419A5 (enExample)
DE10346913A1 (de) Acylhydrazonderivate
JP2004249966A5 (enExample)
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
AR052030A1 (es) Nueva composicion para facilitar el parto humano
Singh et al. Capillary haemangioma on the palate: a diagnostic conundrum
Figueiral et al. The effect of different adhesive materials on retention of maxillary complete dentures.
WO2004069173A3 (en) Methods for modulating an inflammatory response
FR2889062B1 (fr) Composition cosmetique comprenant un copolymere ampholyte
Abdul Ameloglyphics: a forensic tool for human identification
EP1351148A3 (en) Power profiling system and method for correlating runtime information
Pearlstein et al. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment
JPWO2023223065A5 (enExample)
Potdar et al. Evaluation of Salivary IL-8 and Calcium Levels in Postmenopausal Females with and without periodontitis—A Comparative Study
EP1601374A4 (en) COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT OF INFLAMMATION
RU2004103706A (ru) Способ оценки эффективности лечения и прогнозирования риска рекуррентности в течении депрессивных расстройств
Kumakura et al. Relationship between buccal mucosa ridging and viscoelastic behaviour of oral mucosa
RU2003100687A (ru) Способ оценки стрессустойчивости крупного рогатого скота